Close this window

Transaction in Own Shares

09/15/2026
RNS Number : 6177U
Fevertree Drinks PLC
15 September 2026
 

15th September 2026                             

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 7th September to 11th September 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

07 September 2026

XLON

821.8396

24,636

816.5000

827.0000

07 September 2026

AIMX

826.0000

20,000

826.0000

826.0000

08 September 2026

XLON

808.7985

21,854

802.5000

815.0000

08 September 2026

AIMX

805.4982

25,463

800.0000

807.0000

09 September 2026

XLON

811.1779

37,349

793.5000

818.5000

09 September 2026

AIMX

802.0000

10,000

802.0000

802.0000

10 September 2026

XLON

775.7399

31,860

764.0000

818.5000

10 September 2026

AIMX

786.6250

20,000

771.0000

797.0000

11 September 2026

XLON

777.7108

56,529

760.5000

790.5000

11 September 2026

AIMX

779.0000

3,026

779.0000

779.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/6177U_1-2026-9-14.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVZLBFQKLBBBX

Multimedia Files:

Close this window